Retrospective observational study of apatinib in treatment of osteosarcoma after failed standard multimodal therapy
Latest Information Update: 14 Jun 2019
At a glance
- Drugs Rivoceranib (Primary)
- Indications Osteosarcoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Jun 2019 New trial record
- 01 May 2019 Results published in the Medicine